PV

Polaris Venture Management Co IV LLC

Concentrated strategyQuality / disciplined sizingLong-term holder

Total reported value

$62.4M

Reporting period: 2016-09-30 · Number of holdings: 4

Polaris Venture Management Co IV LLC disclosed 4 holdings in its latest 13F filing for the period ending 2016-09-30, with total reported value of $62.4M and a quarterly turnover rate of 10.0%.

Personality snowflake

Concentration
100
Portfolio Stability
9.98
Momentum/Contrarian
50
Sector conviction
0
Diversification
8
Sizing Uniformity
83.75

Recent moves

  • Trim 15708Q105

    0.0% -$1.5M

  • Add XLRN

    0.0% $3.3M

  • Add ALIMEUR

    0.0% $818.0K

  • Trim 74584P103

    0.0% -$493.0K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1XLRNAcceleron Pharma INCStock-Other85.86%+2.50%
2ALIMEURAlimera Sciences INCStock-Other7.52%+1.10%
3Pulmatrix INCStock-Other4.21%-0.96%
4Cerulean Pharma INCStock-Other2.41%-2.64%

Holding changes this quarter

Position changes disclosed by Polaris Venture Management Co IV LLC for the quarter ending 2016-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1XLRNAcceleron Pharma INC+2.5%Unchanged
2ALIMEURAlimera Sciences INC+1.1%Unchanged
3Pulmatrix INC-1%Unchanged
4Cerulean Pharma INC-2.6%Unchanged

FAQ

What is Polaris Venture Management Co IV LLC and what type of investor is it?
Polaris Venture Management Co IV LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2016-09-30), the firm manages a tracked equity portfolio valued at approximately $62.4M, spread across 4 disclosed positions.
What are Polaris Venture Management Co IV LLC's largest equity positions?
Based on the latest 13F filing, Polaris Venture Management Co IV LLC's top holdings by market value are: 1. Acceleron Pharma INC (XLRN) — $53.6M (85.9%) 2. Alimera Sciences INC (ALIMEUR) — $4.7M (7.5%) 3. Pulmatrix INC — $2.6M (4.2%) 4. Cerulean Pharma INC — $1.5M (2.4%)
What changes did Polaris Venture Management Co IV LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Polaris Venture Management Co IV LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Polaris Venture Management Co IV LLC focus on?
Sector breakdown data is not yet available for Polaris Venture Management Co IV LLC. Check back after the next 13F processing cycle.